New K-Oximes (K-27 and K-48) in Comparison with Obidoxime (LuH-6), HI-6, Trimedoxime (TMB-4), and Pralidoxime (2-PAM): Survival in Rats Exposed IP to the Organophosphate Paraoxon

REFERENCES

• Alston T. A. Pralidoxime rescues both muscarinic and nicotinic systems. Anesth. Analg. 2005; 101: 926–927
   Google Scholar
• Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004; 38: 151–216
   PubMed Web of Science ®Google Scholar
• Buckley N., Eddleston M., Szinicz L. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst. Rev. 2005; 1: CD005085
   PubMedGoogle Scholar
• Cox D. R. Regression models and life tables. J.R. Statist. Soc. B 1972; 34: 189–220
   Google Scholar
• Dart R. C., Goldfrank L. R., Chyka P. A., Lotzer D., Woolf A. D., McNally J., Snodgrass W. R., Olson K. R., Scharman E., Geller R. J., Spyker D., Kraft M., Lipsy R. Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann. Emerg. Med. 2000; 36: 126–132
   PubMed Web of Science ®Google Scholar
• Eddleston M., Szinicz L., Eyer P., Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM. 2002; 95: 275–283
   PubMed Web of Science ®Google Scholar
• Hagedorn I. US Patent. 1974; 3852294
   Google Scholar
• Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 2002; 6: 803–816
   Google Scholar
• Kuča K., Bielavský J., Cabal J., Bielavska M. Synthesis of a potential reactivator of acetylcholinesterase–1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett. 2003a; 44: 3123–3125
   Web of Science ®Google Scholar
• Kuča K., Bielavský J., Cabal J., Kassa J. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 2003b; 13: 3545–3547
   PubMed Web of Science ®Google Scholar
• Kuča K., Cabal J., Patočka J., Kassa J. Synthesis of bisquaternary symmetric bis (2-hydroxyiminomethylpyridinium) alkane dibromides and their reactivation of cyclosarin-inhibited acetylcholinesterase. Lett. Org. Chem. 2004; 1: 84–86
   Web of Science ®Google Scholar
• Kuča K., Jun D., Musilek K. Structural requirements for acetylcholinesterase reactivators. Mini Rev. Med. Chem. 2006; 6: 269–277
   PubMed Web of Science ®Google Scholar
• Levine R. Recognized and possible effects of pesticides in humans. Handbook of Pesticide Toxicology, General Principles 1991; 1: 275–360, Hayes, W. J., and Laws, E. R. (Eds.), Academic Press, San Diego
   Google Scholar
• Luettringhaus A., Hagedorn I. Quaternary hydroxy-iminomethylpyridinium salts. The dischloride of bis-(4-hydroxyiminomethyl-1-pyridinium-methyl)-ether (lueh6), a new reactivator of acetylcholinesterase inhibited by organic phosphoric acid esters. Arzneimittelforschung 1964; 14: 1–5
   PubMedGoogle Scholar
• Musilek K., Holas O., Kuka K., Jun D., Dohnal V., Dolezal M. Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 2006; 16(21)5673–5676, Nov 1
   PubMedGoogle Scholar
• Namba T. Cholinesterase inhibition by organophosphorus compounds, and its clinical effects. Bull. WHO 1971; 44: 289–307
   PubMed Web of Science ®Google Scholar
• Namba T., Nolte C. T., Jackrel J., Grob D. Poisoning due to organophosphate insecticides: acute and chronic manifestations. Am. J. Med. 1971; 50: 457–492
   Google Scholar
• Peter J. V., Cherian A. M. Organic insecticides. Anaesth. Intensive Care 2000; 28: 11–21
   PubMed Web of Science ®Google Scholar
• Peter V., Moran J. L., Graham P. Oxime therapy and outcomes in human organophosphate poisoning: An evaluation using meta-analytic techniques. Crit. Care Med. 2006; 34: 502–510
   PubMed Web of Science ®Google Scholar
• Petroianu G., Hardt F., Toomes M., Bergler W., Rüfer R. High-dose intravenous paraoxon exposure does not cause organophosphate induced delayed neuropathy (OPIDN) in mini pigs. J. Appl. Toxicol 2001; 21: 263–268
   PubMed Web of Science ®Google Scholar
• Petroianu G., Toomes L. M., Petroianu A., Bergeler W., Rüfer R. Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini pigs. J. Appl. Toxicol. 1998; 18: 293–298
   PubMed Web of Science ®Google Scholar
• Petroianu G. A., Nurulain S. M., Nagelkerke N., Al-Sultan M. A., Kuca K., Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J. Appl. Toxicol. 2006; 26: 262–268
   PubMed Web of Science ®Google Scholar
• Poziomek E. J., Hackley B. E., Steinberg G. M. Pyridinium aldoximes. J. Organic Chem. 1958; 23: 714–717
   Web of Science ®Google Scholar
• Thompson C. M., Richardson R. J. Anticholinesterase insecticides. Pesticide Toxicology and International Regulation (Current Toxicology Series), T. C. Marrs, B. Ballantyne. John Wiley & Sons Ltd, Chichester 1970; 89–127
   Google Scholar
• Wiener S. W., Hoffman R. S. Nerve agents: a comprehensive review. J. Intensive Care Med. 2004; 19: 22–37
   PubMedGoogle Scholar
• Wilson I. B., Ginsburg S. A powerful reactivator of alkylphosphate. Biochim. Biophys. Acta. 1955; 18: 168–170
   PubMed Web of Science ®Google Scholar
• Zoch E. Die Wirkung organischer Phosphorsäureester bzw. Phosphorsäureesterauf versch. Enzyme. Arzneim. Forschung 1971; 21: 181–187
   Google Scholar